Gen-Probe Files US Regulatory Application for PROGENSA PCA3 Assay
Gen-Probe announced that the Company has submitted a Premarket Approval Application (PMA) to the FDA for its PROGENSA PCA3 assay.
Read MoreGen-Probe announced that the Company has submitted a Premarket Approval Application (PMA) to the FDA for its PROGENSA PCA3 assay.
Read MoreRoche Molecular Diagnostics announced that the FDA has approved the COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0 for use in the United States.
Read MoreVermillion Inc, a molecular diagnostics company, announced that its OVA1 Test is now CE marked, which is a requirement for marketing the test in the European Union.
Read MoreGen-Probe Inc announced that Patrick Sullivan, former chairman, president and chief executive officer of Cytyc Corporation, has been elected to its board of directors.
Read MoreAs the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.
Read More